Respiratory Motion, Inc. and Corestone Biosciences (Beijing) Co., Ltd., have established a Joint Venture Company to deliver monitoring solutions to Chinese health care market and the globe.

Respiratory Motion, Inc. and Corestone Biosciences (Beijing) Co., Ltd., have established a Joint Venture Company to deliver monitoring solutions to Chinese health care market and the globe.

Respiratory Motion, Inc. (Waltham, Massachusetts, USA) the global leader in minute ventilation monitoring and Corestone Biosciences Co., Ltd., an innovative medical device company in anesthesia and analgesia headquartered in Beijing, China have entered into an agreement to form a Joint Venture Company (JV). The JV will offer a new generation of Respiratory Volume Monitors based on Respiratory Motion’s ExSpiron platform, along with other novel critical care solutions for hospital and home markets. The JV will operate out of Zhengzhou in Henan province and through a broad network to deliver its services across China and globally.

See the full release here.

Respiratory Motion, Inc. is excited to announce the launch of the latest ExSpiron 1XiTM Respiratory Monitor

  • The FDA has cleared the newest version of the non-invasive ExSpironTM Minute Ventilation Monitor which does not require calibration.
  • Minute Ventilation (MV) is the earliest indicator of insufficient breathing, and the ExSpiron is the first and only device to provide accurate MV measurements continuously and non-invasively.
  • This new version of the ExSpiron greatly expands the clinical usefulness of the ExSpiron… now assessing breathing and helping to direct care in seconds, “anytime, anywhere”.

Waltham, Mass. (October 17, 2017) – Respiratory Motion, Inc., announced today its plans to launch the newest version of its ExSpiron 1XiTM Minute Ventilation (MV) Monitor at the American Society of Anesthesiologists (ASA) in Boston, October 21-25 following recent FDA 510(k) clearance. This new ExSpiron requires no calibration, which greatly expands its range of use.  Physicians, nurses, respiratory therapists, EMT’s and first responders can now easily assess and measure a patients breathing in seconds. 

See the full release here.

Respiratory Motion Receives CE Mark for ExSpiron™

Waltham, MA (May 26, 2016) - Respiratory Motion, Inc. today announced the CE Mark and full market release of ExSpiron™ for clinical use in CE countries, offering clinicians the only Patient Monitor Measuring Minute Ventilation.  

“Clinicians around the world rely on Minute Ventilation (MV) to make decisions on the respiratory status of patients on mechanical ventilators. ExSpiron™ is the only medical device able to provide this measurement in a patient monitor, offering immediate insight into a patients’ respiratory status than what is available in the market today”, stated Jenny Freeman, MD, CEO of Respiratory Motion. “We are excited to bring Minute Ventilation Monitoring to CE countries with the goal of helping clinicians more rapidly detect changes in respiratory status.”

See the full release here.

Respiratory Motion tackles the Biggest Respiratory Challenges by Monitoring Minute Ventilation at AACN NTI 2016

·   Advanced patient Monitoring of Minute Ventilation presents actionable insights to better manage patients with respiratory challenges in critical care and multiple clinical settings

·   For patients prescribed opioids – the nursing goal is to prevent patients from experiencing respiratory failure using real time data measuring respiratory status

·   Waiting to Exhale -  Minute Ventilation: A New Way to Monitor Breathing” a CEU credited course presented by Dennise Haughton, MSN, ARNP, ACNP-BC, CCRN -  in booth 2155

WALTHAM, MA (May 17, 2016) Respiratory Motion, Inc. (RMI) today announced its participation in the 2016 American Association of Critical Care Nurses National Teaching Institute & Critical Care Exposition (http://bit.do/aacn-NTI) taking place May 16-19 in New Orleans, LA. Committed to helping health care organizations meet their biggest respiratory challenges, Respiratory Motion will showcase it’s ExSpiron™ Minute Ventilation Monitor, the first and only non-invasive method of rapidly determining a patient’s respiratory status.

See the full release here.

Study Shows Advantages of Minute Ventilation Over End-Tidal CO2 In Patients Undergoing Procedural Sedation

Waltham, MA (May 6, 2016) Respiratory Motion, Inc. An independent study by the University of Vermont College of Medicine—being presented this week at the Society for Ambulatory Anesthesia conference in Orlando, FL—indicates that, “Minute Ventilation (MV) monitoring provides superior information versus capnography (EtCO2) in monitoring non-intubated patients forduring procedural sedation.”

 The study, “Respiratory Volume Monitoring Could Improve Safety in Procedural Sedation,” concluded that the use of Respiratory Volume Monitoring (RVM), as a direct measure of adequacy of ventilation, may substantially reduce the amount of time a patient is in “unsafe” MV status, during an endoscopic procedure, by between 45% to 65%. 

See the full release here.

Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Not a member? Sign up. Log Out